Lack of Diversity in Scientific LeadershipPhase 2NCT05171101
The MAVEN Senior Scientist Initiative
A Phase 2 study testing MAVEN in people with Lack of Diversity in Scientific Leadership, run by Northwell Health at 1 site in United States.
Trial summary
MAVEN is an education training program designed to expand the national pool of qualified women and minority candidates for senior scientist positions across all NIGMS areas of science. Read more about this study
- Who is it for?
- Ages 35 years and olderHealthy volunteers can take part
- Conditions the study is for
- Lack of Diversity in Scientific Leadership
- What is being tested?
- MAVEN
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 160 participants
- Where
- 1 siteUnited States
- Study dates
- 21 May 2021to 30 Jun 2026
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Scientists 10 to 15 years from terminal degree in their field
- Identify as an ethnicity, race, or gender which is under-represented in senior levels of faculty.
- Have one or more funded R01 level grant (or equivalent level grant)
Who cannot join
- Scientists <10 or >15 years from terminal degree in their field
- Do not identify as an ethnicity, race, or gender which is under-represented in senior levels of faculty.
- Do not have one or more funded R01 level grant (or equivalent level grant)
Trial locations and contacts
1 site in 1 country.
United States1 site
Institute of Health System Science
New York, New York, 10022
About this study
Official title: The MAVEN Senior Scientist Initiative: A Trial of an Educational Training Program to Accelerate Diversity in Health & Science Leadership
MAVEN is an education training program designed to expand the national pool of qualified women and minority candidates for senior scientist positions across all NIGMS areas of science. Senior scientists (N=160, N=40 per cohort) belonging to an ethnicity, race or gender under-represented at the senior levels of faculty will be enrolled in a randomized 2-arm trial to determine the effects of the MAVEN intervention (comprised of virtual educational sessions and ongoing mentorship) on the following outcomes: 1) increased career satisfaction (primary outcome); 2) peak academic productivity; 3) expanded scientific networks; and 4) leadership ascension.
Read the detailed description
The long-term objective of the MAVEN education training program is to expand the national pool of qualified women and minority candidates for senior scientist positions across all National Institute of General Medical Sciences (NIGMS) areas of science. The investigators intend to create a self-sustaining community committed to inclusive excellence in science. The investigators will do so by adapting best education practices from other industries in executive leadership, strategic career planning, and institution culture change, to create a sustainable, but intensive program with objective evaluation metrics. Using a randomized, 2-arm trial design, the investigators will enroll 40 senior scientists per year in 4 cohorts into the MAVEN study (160 participants total). Participants will be randomized to the MAVEN intervention group or the control group. Participants in the MAVEN group will receive two 7-day virtual institutes focused on senior scientist career planning, respect-based leadership, evidence-based mentoring, organizational culture problem solving, transparency and Open Science, interdisciplinary team collaboration and inclusivity, and effective science thought leadership. These summer institutes will be comprised of didactics, discussions, and interactive individual and team-based activities. Between the institutes there will be 10 months of mentorship, networking, and conduct of institutional change projects. Participants randomized to the control arm will complete all study measures but will not receive access to any of the virtual sessions or mentorship. Target program participants are scientists 10-15 years from their terminal degree , who identify as women, particularly as belonging to an ethnicity or race under-represented at the senior levels of faculty, and who currently hold one or more R01 or equivalent grants. To achieve the MAVEN long-term objective, scientists enrolled in the MAVEN intervention arm will be provided the skills to attain: 1) increased career satisfaction (primary outcome); 2) peak academic productivity; 3) expanded scientific networks; and 4) leadership ascension. Program success will be evaluated primarily by comparison of the control group to MAVEN scientists for change in career satisfaction scores, and also by a blended Major Educational Score Index comprised of h-index, relative citation ratio, number of publications in journals with an impact factor > 5, and annual federal grant dollar amounts. The investigators will also explore changes to professional scientific network size and the leadership ascension between the two groups, tested quantitatively. Primary, secondary, and exploratory outcomes will be evaluated at baseline for each cohort and yearly for all cohorts until the cessation of the program. If the scientific leaders and role models are diverse, the investigators of the current trial stand to benefit from enrichment of the pool of future investigators, the broader perspective in research agenda prioritization, the greater success in recruiting diverse research participants, and the enhanced ability to advance science to reduce health disparities.
- Being tested
- MAVEN
- Keywords
- Science, Scientists, Leadership, Women, Minority, Diversity, Virtual, Educational, Mentoring
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MAVENOther
The MAVEN education training program will be comprised of a 7-day virtual summer institute and a 7-day second virtual summer institute focused on respect-based leadership, senior scientist career planning, evidence-based mentoring, organizational culture problem solving, interdisciplinary team collaboration and inclusivity, effective science thought leadership, and public engagement. These summer institutes will be comprised of didactics, discussions, and interactive individual and team-based activities. Between the institutes there will be 10 months of mentorship, networking, and conduct of institutional change projects.
| Study group | Role | What they receive |
|---|---|---|
| MAVEN | Experimental | Not described Receives: Other: MAVEN |
| Control | No intervention | Participants enrolled in the control group will receive no mentoring activities but will complete all study measures and assessments. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Career Satisfaction
Measured using the C-Change faculty satisfaction survey, a 74-item questionnaire assessing 12 areas including vitality, self-efficacy in career advancement, institutional support, relationships/inclusion/trust, values alignment, ethical/moral distress, respect, mentoring, leadership aspirations, work-life integration, gender equity, and equity for members of groups under-represented in medicine. Differences between the MAVEN and control groups will be assessed using a linear mixed model that includes an effect for treatment group, a fixed time effect, and group-time interaction, while accounting for within-subject correlation with a participant random effect. The investigators will use all observed data in an intent-to-treat manner. Investigators will also conduct GEE as a sensitivity analysis and each of the questions used in the survey will be summarized using proportions, and compared using Mann Whitney tests.
Measured: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort..
Secondary outcomes (1)
Academic Productivity
Measured using the blended Major Educational Score Index (MESI). MESI will be a composite of four variables. First, the investigators will calculate the h-index from the Science Citation Index based on the number of peer-reviewed publications >h. Second, the investigators will compute the annual relative citation ratio, a quantitative assessment of scientific productivity, designed to assess the influence of a research article by considering its co-citation network and by field-normalizing that estimate. Third, the investigators will obtain the annual number of publications in journals with an impact factor 5 or above, and fourth, annual federal grant dollar amounts. MESI scores at program-end will be captured from various sources, standardized, and analyzed using linear mixed models, comparing the two groups with covariate adjustment. Detecting a significant difference between the MAVEN group and the control group at program-end would indicate success at attaining this objective.
Measured: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Dec 2021
- Study start21 May 2021
- Primary completion21 May 2026 (estimated)
- Study completion30 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lack of Diversity in Scientific LeadershipStudies of the same condition, open and under way.
- More trials run by Northwell HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Educational RCT
- Masking
- None (open label)
- Enrolment
- 160 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Northwell Health
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH)
- Responsible party
- Sponsor
- Investigators
- Karina Davidson, PhD, MASc, Principal investigator, Northwell Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05171101
- Sponsor's protocol ID
- 20-0347
- Status last verified
- Feb 2024
- First submitted
- 11 Jun 2021
- Last updated
- 14 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be distributed. For program material deposit, the investigators will make all materials available from the MAVEN institute via the appropriate web internet repositories such as ABT, BEN Portal, MedEdPORTAL, NRMN, CTSA WIKI, NIH Distinguished Scholars Program, https://diversity.nih.gov/programs-partnerships/dsp, and other such entities. The trial pre-registration materials will be disseminated at Open Science and at clinicaltrials.gov. As stated in the Outcomes Data Collection and Storage Plan, all code, and data dictionaries and publications will be available in an Open Science framework. The investigators look forward to sharing curricula, group exercises, created case studies, other pedagogical materials, and evaluation plans and resulting data and findings with other diversity programs and with other training programs throughout the nation.
Study at a glance
From the registry record, last updated by the sponsor on 14 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The MAVEN Senior Scientist Initiative: A Trial of an Educational Training Program to Accelerate Diversity in Health & Science Leadership
- ClinicalTrials.gov ID
- NCT05171101
- Acronym / sponsor ID
- 20-0347
- Keywords
- Science, Scientists, Leadership, Women, Minority, Diversity, Virtual, Educational
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 160 participants (estimated)
- Lead sponsor
- Northwell HealthUniversity, hospital or other
- Collaborators
- National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH)
- Study start
- 21 May 2021 (actual)
- Primary completion
- 21 May 2026 (estimated)
- Study completion
- 30 Jun 2026 (estimated)
- First posted
- 28 Dec 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
MAVEN is an education training program designed to expand the national pool of qualified women and minority candidates for senior scientist positions across all NIGMS areas of science. Senior scientists (N=160, N=40 per cohort) belonging to an ethnicity, race or gender under-represented at the senior levels of faculty will be enrolled in a randomized 2-arm trial to determine the effects of the MAVEN intervention (comprised of virtual educational sessions and ongoing mentorship) on the following outcomes: 1) increased career satisfaction (primary outcome); 2) peak academic productivity; 3) expanded scientific networks; and 4) leadership ascension.
Detailed description
The long-term objective of the MAVEN education training program is to expand the national pool of qualified women and minority candidates for senior scientist positions across all National Institute of General Medical Sciences (NIGMS) areas of science. The investigators intend to create a self-sustaining community committed to inclusive excellence in science. The investigators will do so by adapting best education practices from other industries in executive leadership, strategic career planning, and institution culture change, to create a sustainable, but intensive program with objective evaluation metrics. Using a randomized, 2-arm trial design, the investigators will enroll 40 senior scientists per year in 4 cohorts into the MAVEN study (160 participants total). Participants will be randomized to the MAVEN intervention group or the control group. Participants in the MAVEN group will receive two 7-day virtual institutes focused on senior scientist career planning, respect-based leadership, evidence-based mentoring, organizational culture problem solving, transparency and Open Science, interdisciplinary team collaboration and inclusivity, and effective science thought leadership. These summer institutes will be comprised of didactics, discussions, and interactive individual and team-based activities. Between the institutes there will be 10 months of mentorship, networking, and conduct of institutional change projects. Participants randomized to the control arm will complete all study measures but will not receive access to any of the virtual sessions or mentorship. Target program participants are scientists 10-15 years from their terminal degree , who identify as women, particularly as belonging to an ethnicity or race under-represented at the senior levels of faculty, and who currently hold one or more R01 or equivalent grants. To achieve the MAVEN long-term objective, scientists enrolled in the MAVEN intervention arm will be provided the skills to attain: 1) increased career satisfaction (primary outcome); 2) peak academic productivity; 3) expanded scientific networks; and 4) leadership ascension. Program success will be evaluated primarily by comparison of the control group to MAVEN scientists for change in career satisfaction scores, and also by a blended Major Educational Score Index comprised of h-index, relative citation ratio, number of publications in journals with an impact factor > 5, and annual federal grant dollar amounts. The investigators will also explore changes to professional scientific network size and the leadership ascension between the two groups, tested quantitatively. Primary, secondary, and exploratory outcomes will be evaluated at baseline for each cohort and yearly for all cohorts until the cessation of the program. If the scientific leaders and role models are diverse, the investigators of the current trial stand to benefit from enrichment of the pool of future investigators, the broader perspective in research agenda prioritization, the greater success in recruiting diverse research participants, and the enhanced ability to advance science to reduce health disparities.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized Educational RCT
| Arm | Type | Receives |
|---|---|---|
| MAVEN | Experimental | Other: MAVEN |
| Control | No intervention | –Participants enrolled in the control group will receive no mentoring activities but will complete all study measures and assessments. |
Who may qualify
- Ages
- 35 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Scientists 10 to 15 years from terminal degree in their field
- Identify as an ethnicity, race, or gender which is under-represented in senior levels of faculty.
- Have one or more funded R01 level grant (or equivalent level grant)
Key exclusion criteria (3 listed)
- Scientists <10 or >15 years from terminal degree in their field
- Do not identify as an ethnicity, race, or gender which is under-represented in senior levels of faculty.
- Do not have one or more funded R01 level grant (or equivalent level grant)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MAVENThe MAVEN education training program will be comprised of a 7-day virtual summer institute and a 7-day second virtual summer institute focused on respect-based leadership, senior scientist career planning, evidence-based mentoring, organizational culture problem solving, interdisciplinary team collaboration and inclusivity, effective science thought leadership, and public engagement. These summer institutes will be comprised of didactics, discussions, and interactive individual and team-based activities. Between the institutes there will be 10 months of mentorship, networking, and conduct of institutional change projects. | Other | MAVEN |
Primary outcome
Career Satisfaction
Time frame: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort..
Measured using the C-Change faculty satisfaction survey, a 74-item questionnaire assessing 12 areas including vitality, self-efficacy in career advancement, institutional support, relationships/inclusion/trust, values alignment, ethical/moral distress, respect, mentoring, leadership aspirations, work-life integration, gender equity, and equity for members of groups under-represented in medicine. Differences between the MAVEN and control groups will be assessed using a linear mixed model that includes an effect for treatment group, a fixed time effect, and group-time interaction, while accounting for within-subject correlation with a participant random effect. The investigators will use all observed data in an intent-to-treat manner. Investigators will also conduct GEE as a sensitivity analysis and each of the questions used in the survey will be summarized using proportions, and compared using Mann Whitney tests.
1 secondary outcome
Academic Productivity
Time frame: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Feb 2024.
- Individual participant dataSharing planned: No. Individual participant data will not be distributed. For program material deposit, the investigators will make all materials available from the MAVEN institute via the appropriate web internet repositories such as ABT, BEN Portal, MedEdPORTAL, NRMN, CTSA WIKI, NIH Distinguished Scholars Program, https://diversity.nih.gov/programs-partnerships/dsp, and other such entities. The trial pre-registration materials will be disseminated at Open Science and at clinicaltrials.gov. As stated in the Outcomes Data Collection and Storage Plan, all code, and data dictionaries and publications will be available in an Open Science framework. The investigators look forward to sharing curricula, group exercises, created case studies, other pedagogical materials, and evaluation plans and resulting data and findings with other diversity programs and with other training programs throughout the nation.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Karina Davidson, PhD, MASc principal investigator
Northwell Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing MAVEN in people with Lack of Diversity in Scientific Leadership, run by Northwell Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Career Satisfaction (time frame: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort..). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2024.